Gastroenterologìa (Apr 2015)
Proton Pump Inhibitors and Risk of Drug Interactions
Abstract
In the article, the current data regarding drug interactions of proton pomp inhibitors (PPI) with other preparations are discussed. It is concluded that the risk of adverse drug interactions is enhanced by the use of PPIs and drugs primarily metabolized by cytochrome isoenzyme CYP2C19. If the simultaneous application of IPP with many other drugs, including clopidogrel, is necessary, the preference should be given to pantoprazole.
Keywords